Autologous transfusions for elective surgery – from existing approaches to upcoming challenges

Aleksandar Miodrag Jevtić; Milena Todorović; Gordana Ostojić; Saša Vasilijić; Mirjana Pavlović; Bela Balint

doi:10.2298/VSP151218255J

Aleksandar Miodrag Jevtić Military Medical Academy, Clinic for Orthopedic Surgery, Belgrade Serbia
Milena Todorović Clinical Center of Serbia, Clinic for Hematology, Belgrade, Serbia.
Gordana Ostojić Military Medical Academy, Institute for Transfusiology and Hemobiology, Belgrade, Serbia; University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
Saša Vasilijić University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia; Military Medical Academy, Institute for Medical Research, Belgrade Serbia.
Mirjana Pavlović Florida Atlantic University, Department of Computer and Electrical Engineering and Computer Science, BocaRaton, Florida, United States of America.
Bela Balint Military Medical Academy, Institute for Transfusiology and Hemobiology, Belgrade Serbia; University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia; University of Belgrade, Institute for Medical Research, Belgrade, Serbia.

DOI: https://doi.org/10.2298/VSP151218255J

Keywords: blood transfusion, autologous, blood component transfusion, elective surgical procedures,

References

Radović M, Balint B. Intervention for reducing homologous transfusion use. Belgrade: Association ART; 1995. (Serbian)

Gligorović V, Balint B. Clinical transfusiology. Belgrade: The In-stitute for Textbooks Teaching Aids; 1998. (Serbian)

Balint B. Clinical transfusiology. Belgrade: The Institute for Textbooks Teaching Aids; 2004. (Serbian)

Balint B, Trkuljić M, Todorović M. Basic principles of haemothe-rapy. Belgrade: Čigoja; 2010. (Serbian)

Balint B, Vucetic D, Ostojic G, Ljubenov M. Basic of transfusiology with haemotiology. Belgrade: Faculty of Medicine of the Military Medical Academy – Media Center „Odbrana”; 2015. (Serbian)

Roback JD, Grossman BJ, Harris T, Hillyer CD. Technical manual. 17th ed. Bethesda, MD: AABB Press; 2011.

Klein HG, Anstee DJ. Mollison's Blood transfusion in clinical medicine. 12th ed. Oxford: Wiley-Blackwell; 2014.

Long M, Liu Z, Zhu J. Comparative analysis of autologous blood transfusion and allogeneic blood transfusion in surgical patients. Int J Clin Exp Med 2014; 7(9): 2889−94.

Rhee P, Inaba K, Pandit V, Khalil M, Siboni S, Vercruysse G, et al. Early autologous fresh whole blood transfusion leads to less allogeneic transfusions and is safe. J Trauma Acute Care Surg 2015; 78(4):729-34. PubMed PMID: 25807402

Catalano L, Campolongo A, Caponera M, Berzuini A, Bontadini A, Furlò G, et al. Indications and organisational methods for autologous blood transfusion procedures in Italy: Results of a national survey. Blood Transfus 2014; 12(4): 97−508.

Guo J, Xu F, Jin X, Shen H, Liu Y, Zhang Y, et al. Impact of al-logenic and autologous transfusion on immune function in patients with tumors. Asian Pac J Cancer Prev 2014; 15(1): 467−74.

Stanković B, Balint B, Taseski J, Trkuljić M, Jovanović Z, Kilibarda N. Perioperative use of rhEPO in female patient included in the program of autologous blood transfusion. Anest Reanim Transf 1997; 26: 53−6. (Serbian)

Stankovic B, Balint B, Taseski J, Trkuljic M, Jovanovic Z. Preopera-tive use of the ferrous sulfate and rhEPO in the autologous transfusion (AT) program. Vox Sang 1998; 74(Suppl 1): 1595, E.

Menendez ME, Ring D. Minorities are less likely to receive auto-logous blood transfusion for major elective orthopaedic sur-gery. Clin Orthop Relat Res 2014; 472(11): 3559−66.

Yoo M, Park H, Ryu J, Kim J. The efficacy and safety of auto-logous transfusion in unilateral total knee arthroplasty. Knee Surg Relat Res 2015; 27(3): 168−72.

Schneider MM, Kendoff D, Oloughlin PF, Hessling C, Gehrke T, Citak M. Effectiveness of autologous transfusion system in primary total hip and knee arthroplasty. Technol Health Care 2014; 22(1): 123−8.

Hawi N, Kendoff DO, Hessling U, Haasper C, Gehrke T, Citak M. Effectiveness of an autologous transfusion system following cemented and non-cemented revisions of total hip arthroplas-ty. Int Orthop 2014; 38(8): 1603−8.

Horstmann W, Kuipers B, Ohanis D, Slappendel R, Kollen B, Verheyen C. Autologous re-transfusion drain compared with no drain in total knee arthroplasty: A randomised controlled trial. Blood Transfus 2014;12(Suppl 1): s176−81.

Horstmann WG, Swierstra MJ, Ohanis D, Rolink R, Kollen BJ, Ver-heyen C. Favourable results of a new intraoperative and post-operative filtered autologous blood re-transfusion system in total hip arthroplasty: A randomised controlled trial. Int Or-thop 2014; 38(1): 13−8.

Li N, Li P, Liu M, Wang D, Xia L. Comparison between auto-logous blood transfusion drainage and no drainage/closed-suction drainage in primary total hip arthroplasty: A meta-analysis. Arch Orthop Trauma Surg 2014; 134(11): 1623−31.

Tesic I, Sekulic J, Arbutinov V, Popov D, Velisavljev D. Autologous blood transfusion in patients undergoing hip replacement sur-gery. Med Pregl 2014; 67(3−4): 101−7.

Newman ET, Watters TS, Lewis JS, Jennings JM, Wellman SS, At-tarian DE, et al. Impact of perioperative allogeneic and auto-logous blood transfusion on acute wound infection following total knee and total hip arthroplasty. J Bone Joint Surg Am 2014; 96(4): 279−84.

Kumar S, Goyal K, Dubey S, Bindra A, Kedia S. Anaphylactic reaction after autologous blood transfusion: A case report and review of the literature. Asian J Neurosurg 2015; 10(2): 145−7.

Xing Y, Wang Y. Influence of autologous and homologous blood transfusion on interleukins and tumor necrosis factor-α in peri-operative patients with esophageal cancer. Asian Pac J Cancer Prev 2014; 15(18): 7831−4.

Suzuki Y, Okai K, Ohashi H, Aota S, Sakurai K, Terawaki H, et al. Autologous blood transfusion for hemodialysis patients: A case report and review of clinical reports and therapeutic fea-tures. Transf Apher Sci 2015; 52(2): 204−7.

Trapp C, Schiller W, Mellert F, Halbe M, Lorenzen H, Welz A, et al. Retrograde Autologous Priming as a Safe and Easy Method to Reduce Hemodilution and Transfusion Requirements during Cardiac Surgery. Thorac Cardiovasc Surg 2015; 63(7): 628−34.

Chalfin HJ, Frank SM, Feng Z, Trock BJ, Drake CG, Partin AW, et al. Allogeneic versus autologous blood transfusion and sur-vival after radical prostatectomy. Transfusion 2014; 54(9): 2168−74.

Shukla P, Dwivedi S, Bhargava M, Singh R, Singh S. Intraoperative autologous blood transfusion of peritoneal blood during lapa-rotomy for ectopic pregnancy: Prospective study. J Obstet Gynaecol India 2014; 64(5): 358−61.

Mercuriali F, Zanella A, Barosi G, Inghilleri G, Biffi E, Vinci A, et al. Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion 1993; 33(1): 55−60.

Mercuriali F, Inghilleri G, Biffi E, Colotti MT, Vinci A, Sinigaglia L, et al. Comparison between intravenous and subcutaneous re-combinant human erythropoietin (Epoetin alfa) administration in presurgical autologous blood donation in anemic rheumato-id arthritis patients undergoing major orthopedic surgery. Vox Sang 1997; 72(2): 93−100.

Price TH, Goodnough LT, Vogler WR, Sacher RA, Hellman RM, Johnston MF, et al. The effect of recombinant human erythro-poietin on the efficacy of autologous blood donation in pa-tients with low hematocrits: A multicenter, randomized, double-blind, controlled trial. Transfusion 1996; 36(1): 29−36.

Biesma DH, Marx JJ, Kraaijenhagen RJ, Franke W, Messinger D, Van de Wiel A. Lower homologous blood requirement in auto-logous blood donors after treatment with recombinant human erythropoietin. Lancet 1994; 344(8919): 367−70.